KBY Biotech Indexv0.0.34
Search
← Pipeline|Capicagene

Capicagene

Approved
GW-9104
By GW Pharma (Jazz)
Source: Trial-derived·Trials: 4
Modality
Bispecific Ab
MOA
C5i
Target
TIM-3
Pathway
Autophagy
PsAAsthma
Development Pipeline
Preclinical
~Oct 2011
→ ~Jan 2013
Phase 1
~Apr 2013
→ ~Jul 2014
Phase 2
~Oct 2014
→ ~Jan 2016
Phase 3
~Apr 2016
→ ~Jul 2017
NDA/BLA
~Oct 2017
→ ~Jan 2019
Approved
Apr 2019
→ Feb 2031
ApprovedCurrent
NCT04685308
2,049 pts·Asthma
2021-02→2030-05·Not yet recruiting
NCT08445860
2,459 pts·Asthma
2021-10→2031-02·Terminated
NCT05896362
996 pts·PsA
2020-12→2028-04·Completed
+1 more trial
6,668 total pts2 indications
CompletedCurrentUpcoming
Catalysts (4)
2028-01-061.8y awayPh3 Readout· Asthma
2028-04-042.0y awayPh3 Readout· PsA
2030-05-064.1y awayPh3 Readout· Asthma
2031-02-224.9y awayPh3 Readout· Asthma
Trial Timeline
Q2Q3Q42020Q2Q3Q42021Q2Q3Q42022Q2Q3Q42023Q2Q3Q42024Q2Q3Q42025Q2Q3Q42026Q2Q3Q42027Q2Q3Q42028Q2Q3Q42029Q2Q3Q42030Q2Q3Q42031Q2
Approved
Not yet…
Approved
Complet…
Approved
Not yet…
Approved
Termina…
Catalysts
Ph3 Readout
2028-01-06 · 1.8y away
Asthma
Ph3 Readout
2028-04-04 · 2.0y away
PsA
Ph3 Readout
2030-05-06 · 4.1y away
Asthma
Ph3 Readout
2031-02-22 · 4.9y away
Asthma
CompletedTerminatedNot yet recruiting|StartCompletionToday
Trials (4)
NCTPhaseIndicationStatusNEP
NCT04685308ApprovedAsthmaNot yet recr...2049eGFR
NCT08445860ApprovedAsthmaTerminated2459UPCR
NCT05896362ApprovedPsACompleted996EASI-75
NCT03562500ApprovedAsthmaNot yet recr...1164EASI-75
Competitors (10)
DrugCompanyPhaseTargetMOA
DSN-2247Daiichi SankyoNDA/BLAEZH2C5i
REG-6699RegeneronPhase 2/3TIM-3FcRni
NidasacituzumabUnited TherapeuticsPhase 1/2TIM-3ALKi
RimabrutinibMadrigal PharmaPhase 1/2GPRC5DC5i
LiratinibKrystal BiotechNDA/BLATIM-3EZH2i
DoxazasiranAxsomePhase 1TIM-3IL-17i
XEN-577Xenon PharmaPhase 2/3C5C5i
RimanesiranMerusPhase 1TIM-3FXIai
NiratinibAlumisNDA/BLATIM-3CFTRmod
TER-8735TernsPhase 1/2TIM-3STINGag